comparative effectiveness of semaglutide and tirzepatide vs bariatric surgery Single vs. Dual Agonist Pharmacotherapy for Managing Insufficient Weight Loss Weight Regain Following Metabolic and Surgery: A Review comparative effectiveness of semaglutide and

We are here to walk you through the entire wellness and weight loss process safely and with great results.

A 20% - 30% coinsurance could be implemented for GLP-1s for weight loss

Heres a detailed breakdown: Common side effects: Both medications can cause gastrointestinal issues such as: Nausea Diarrhea Vomiting Constipation Decreased appetite Abdominal pain and discomfort Additional side effects reported by Zepbound users include: Injection site reactions Fatigue Allergic reactions Belching Hair loss Heartburn Serious side effects: There is a potential risk of severe stomach problems and kidney failure Serious allergic reactions are possible, requiring immediate medical attention Both medications may cause hypoglycemia, especially when used with other diabetes drugs Patients should be monitored for depression or thoughts of suicide Interactions and considerations: Tirzepatide and Zepbound can delay gastric emptying, which may impact how other oral medications are absorbed Both have a half-life of 120 hours and are not classified under the Controlled Substances Act Disease interactions include: Thyroid cancer Acute kidney injury Pancreatitis Retinopathy Severe gastrointestinal disease While Tirzepatide has been studied extensively and is deemed safe for eligible patients, healthcare providers should evaluate each patients health history and current condition to ensure the benefits outweigh the risks

Diabetes-related healthcare expenditure in Portugal was estimated to exceed EUR 1.3 billion in 2018 and EUR 1.6 billion in 2019, equating to approximately 78% of the total healthcare budget and 0.60.8% of Portuguese gross domestic product [1, 2]